Want to see CH:CPHN full AI Analyst Report?
Top Page
CPH Group AG Class A
(CPHN)
Select Model
Select Model
Rating:65Neutral
Price Target:
CHF62.00
▲(6.53% Upside)
Action:Reiterated
Date:08/04/26
The score is driven primarily by improved financial performance in 2025 and a comparatively sound balance sheet, tempered by historically volatile revenue/cash-flow consistency and weaker cash conversion. Technicals add only moderate support due to mixed short-term strength versus a weaker longer-term trend, while valuation is a modest positive on a reasonable P/E and solid dividend yield.
Positive Factors
Profitability rebound
The 2025 margin recovery (roughly 48% gross and 7% net) suggests improved pricing, mix or cost control in specialty chemicals and/or tighter portfolio management. Sustained margins bolster internal cash available for reinvestment, dividends and buffer against cyclical downturns over the medium term.
Negative Factors
Revenue cyclicality
Historic cyclicality and a prior major loss year underline that end-market exposure (petrochemical, gas drying, life-science purification) drives uneven revenue and profit. Such volatility weakens predictability of earnings, complicates capital allocation and increases the need for conservative balance-sheet management.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability rebound
The 2025 margin recovery (roughly 48% gross and 7% net) suggests improved pricing, mix or cost control in specialty chemicals and/or tighter portfolio management. Sustained margins bolster internal cash available for reinvestment, dividends and buffer against cyclical downturns over the medium term.
Read all positive factors
CPH Group AG Class A (CPHN) vs. iShares MSCI Switzerland ETF (EWL)
Market Cap
CHF351.58M
Dividend Yield3.41%
Average Volume (3M)1.00K
Price to Earnings (P/E)17.1
Beta (1Y)0.34
Revenue Growth3.69%
EPS Growth-32.66%
CountryCH
Employees1,249
SectorGeneral
Sector StrengthN/A
IndustryPaper, Lumber & Forest Products
Share Statistics
EPS (TTM)3.43
Shares Outstanding6,000,000
10 Day Avg. Volume835
30 Day Avg. Volume1,003
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)2.04
Price to Sales (P/S)1.24
P/FCF Ratio32.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)4.07
Revenue Forecast (FY)CHF348.00M
CPH Group AG Class A Business Overview & Revenue Model
Company Description
CPH Chemie + Papier Holding AG, along with its various group entities, focuses on the innovation, manufacture, and commercialization of chemicals, paper for printing, and specialized packaging films for the pharmaceutical sector. The Chemistry seg...
How the Company Makes Money
CPH Group AG generates revenue primarily through two pillars: (1) its specialty chemicals business and (2) its real estate business. In specialty chemicals, the Zeochem segment sells molecular sieves, chromatography gels, and related adsorbent/pro...
CPH Group AG Class A Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
74
Positive
Cash Flow
56
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 334.23M | 334.06M | 447.86M | 623.98M | 725.35M | 496.69M |
| Gross Profit | 116.05M | 159.50M | 162.31M | 224.67M | 125.21M | -2.92M |
| EBITDA | 47.16M | 49.06M | 30.90M | 113.06M | 131.09M | -117.87M |
| Net Income | 20.49M | 23.36M | 4.65M | 78.89M | 100.95M | -151.56M |
Balance Sheet | ||||||
| Total Assets | 392.86M | 368.86M | 332.61M | 598.19M | 666.19M | 560.40M |
| Cash, Cash Equivalents and Short-Term Investments | 32.96M | 27.04M | 31.60M | 107.64M | 143.61M | 95.12M |
| Total Debt | 58.40M | 53.23M | 18.94M | 723.00K | 98.85M | 109.82M |
| Total Liabilities | 182.58M | 164.99M | 123.16M | 161.92M | 266.62M | 249.90M |
| Stockholders Equity | 210.27M | 203.50M | 209.45M | 436.27M | 398.21M | 309.13M |
Cash Flow | ||||||
| Free Cash Flow | 30.18M | 12.82M | 22.69M | 75.22M | 63.72M | -8.76M |
| Operating Cash Flow | 50.50M | 34.07M | 45.68M | 109.86M | 97.63M | 15.83M |
| Investing Cash Flow | -33.45M | -50.89M | -46.74M | -18.00M | -29.62M | -19.22M |
| Financing Cash Flow | -10.60M | 13.52M | -75.52M | -125.66M | -18.99M | -17.98M |
CPH Group AG Class A Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | CHF265.27M | 9.64 | 11.74% | 3.63% | -1.24% | -11.13% | |
65 Neutral | CHF351.58M | 17.08 | ― | 3.44% | 3.69% | -32.66% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | CHF390.71M | -41.64 | ― | ― | -2.66% | 9.28% | |
53 Neutral | CHF430.18M | -120.56 | ― | 2.74% | -4.83% | -139.13% | |
53 Neutral | CHF368.47M | 3,572.00 | ― | 1.22% | -6.64% | ― | |
48 Neutral | CHF308.56M | -7.46 | -6.84% | 1.50% | -1.69% | 30.59% |
* General Sector Average
CH:CPHN
CPH Group AG Class A
59.00
-7.86
-11.75%
CH:KOMN
Komax Holding AG
76.60
-8.60
-10.09%
CH:BYS
Bystronic
151.20
-216.64
-58.90%
CH:MIKN
Mikron Holding AG
16.50
-1.37
-7.67%
CH:VETN
Vetropack Holding AG Class A
21.55
-3.25
-13.11%
CH:MEDX
medmix AG
9.02
-1.70
-15.87%
CPH Group AG Class A Corporate Events
CPH Group Lifts Payout Ratio as Packaging Strength Offsets Zeochem Slowdown
Jul 21, 2026
CPH Group reported stable first-half 2026 sales of CHF 176 million and EBITDA of CHF 28.3 million, with an improved EBITDA margin of 16.1% back in its target range, supported by cost reductions and a richer product mix at Perlen Packaging. Net pro...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.